Alvaro Sanchez, Jose Ignacio Pijoan, Rita Sainz de Rozas, Itxasne Lekue, Ricardo San Vicente, Jose Antonio Quindimil, Rafael Rotaeche, Arritxu Etxeberria, Carmela Mozo, Monica Martinez-Cengotitabengoa, Monica Monge, Cristina Gómez-Ramírez, Ricardo Samper, Mikel Ogueta Lana, Sara Celorrio, Nerea Merino-Inda, Marta Llarena, Marta Gonzalez Saenz de Tejada, Arturo García-Alvarez, Gonzalo Grandes
INTRODUCTION: This study aims to reduce potentially inappropriate prescribing (PIP) of statins and foster healthy lifestyle promotion in cardiovascular disease (CVD) primary prevention in low-risk patients. To this end, we will compare the effectiveness and feasibility of several de-implementation strategies developed following the structured design process of the Behaviour Change Wheel targeting key determinants of the clinical decision-making process in CVD prevention. METHODS AND ANALYSIS: A cluster randomised implementation trial, with an additional control group, will be launched, involving family physicians (FPs) from 13 Integrated Healthcare Organisations (IHOs) of Osakidetza-Basque Health Service with non-zero incidence rates of PIP of statins in 2021...
April 17, 2024: BMJ Open